Gene · 6317
Papers2,569
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,569
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A nomogram combining thoracic CT and tumor markers to predict the malignant grade of pulmonary nodules ≤3 cm in diameter. | Front Oncol | 2023 | 37361581 | PubTator, text mining | PubMed |
| Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. | Cochrane Database Syst Rev | 2023 | 37335995 | PubTator, text mining | PubMed |
| New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review). | Int J Oncol | 2023 | 37326100 | PubTator, text mining | PubMed |
| Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence. | Biochem Soc Trans | 2023 | 37294003 | PubTator, text mining | PubMed |
| Pilot study of plasma creatine riboside as a potential biomarker for cervical cancer. | Heliyon | 2023 | 37292314 | PubTator, text mining | PubMed |
| Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors. | Cancer Imaging | 2023 | 37291665 | PubTator, text mining | PubMed |
| SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production. | J Clin Invest | 2023 | 37279067 | PubTator, text mining | PubMed |
| High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid. | J Cancer Res Clin Oncol | 2023 | 37270459 | PubTator, text mining | PubMed |
| Plasma versican and plasma exosomal versican as potential diagnostic markers for non-small cell lung cancer. | Respir Res | 2023 | 37259101 | PubTator, text mining | PubMed |
| Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition. | Biomolecules | 2023 | 37238609 | PubTator, text mining | PubMed |
| Controversies in the Staging of Patients with Locally Advanced Cervical Cancer. | Diagnostics (Basel) | 2023 | 37238231 | PubTator, text mining | PubMed |
| Current Molecular, Cellular and Genetic Aspects of Peri-Implantitis Disease: A Narrative Review. | Dent J (Basel) | 2023 | 37232785 | PubTator, text mining | PubMed |
| How brain networks tic: Predicting tic severity through rs-fMRI dynamics in Tourette syndrome. | Hum Brain Mapp | 2023 | 37232486 | PubTator, text mining | PubMed |
| Transcriptome-wide gene-gene interaction associations elucidate pathways and functional enrichment of complex traits. | PLoS Genet | 2023 | 37216417 | PubTator, text mining | PubMed |
| Does pollen exposure influence innate immunity to SARS-CoV-2 in allergy or asthma? | J Allergy Clin Immunol | 2023 | 37211056 | PubTator, text mining | PubMed |
| Preoperative diagnosis of solitary pulmonary nodules with a novel hematological index model based on circulating tumor cells. | Front Oncol | 2023 | 37207165 | PubTator, text mining | PubMed |
| Detection of serum HE4 levels contributes to the diagnosis of lung cancer. | Oncol Lett | 2023 | 37205918 | PubTator, text mining | PubMed |
| Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma. | Cancers (Basel) | 2023 | 37190290 | PubTator, text mining | PubMed |
| Multi-Omics Research Strategies for Psoriasis and Atopic Dermatitis. | Int J Mol Sci | 2023 | 37175722 | PubTator, text mining | PubMed |
| Anti-PD-1 monoclonal antibody-resistant esophageal squamous cell carcinoma showing the abscopal effect: A case report with T-cell receptor/B-cell receptor repertoire analysis. | Cancer Rep (Hoboken) | 2023 | 37165926 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6317/papers?page=13